A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor Xa Inhibitor

Grants and Contracts Details

StatusFinished
Effective start/end date12/1/21 → 1/16/24

Funding

  • Portola Pharmaceuticals Inc.: $64,245.00